Skip to main content
MarketsReportedMedium
5.0

Leo Pharma postpones Copenhagen IPO amid market conditions

Nordic Capital-backed Leo Pharma has delayed its planned Copenhagen listing, originally targeted before year-end. The move signals caution in European IPO markets, likely due to volatile conditions. This is a notable setback for private equity exit plans and reflects broader risk-off sentiment in equity capital markets.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

Dagens Industri3 days agoDKCredibility 26%View source

Score Breakdown

Mosaic Score5.0
Model confidence0.5
Significance0.5
Source credibility0.3

Intelligence Tags

Locations

Copenhagen
Source

Related signals

8 found